Caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy

doi:10.3748/wjg.v18.i16.1915

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 16

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3009)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

301

HTML

2457

Figures (1-2)

127

Tables (1-3)

124

Sum=3009

Apr 28, 2012 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Apr 28, 2012; 18(16): 1915-1920
Published online Apr 28, 2012. doi: 10.3748/wjg.v18.i16.1915

Full Size Figure Download Figure

Figure 2 Kaplan Meier curves representing the relationship between caspase-cleaved cytokeratin-18 and disease-specific survival. A: In months from time of diagnosis in patients who received primary surgery only; B: In patients who received neoadjuvant chemotherapy.

Citation: Fareed KR, Soomro IN, Hameed K, Arora A, Lobo DN, Parsons SL, Madhusudan S. Caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy. World J Gastroenterol 2012; 18(16): 1915-1920
URL: https://www.wjgnet.com/1007-9327/full/v18/i16/1915.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i16.1915